Farms.com Home   Farm Equipment News

Unverferth Manufacturing Announces Shell Rock Expansion

Unverferth Manufacturing Co. Inc. has announced that its Shell Rock, Iowa, facility has nearly completed a 75,000-square-foot plant expansion.
Unverferth Manufacturing Co. Inc. has announced that its Shell Rock, Iowa facility has nearly completed a 75,000-square-foot plant expansion.

This will mark the facility’s 12th expansion since 1988 and an additional 65 job openings for welders, painters, robotic operators, machine operators, and general assemblers. “This is an exciting time for Unverferth and the communities surrounding Shell Rock,” said Larry Unverferth, president for the company. “We often say, ‘Employees are not numbers at Unverferth; they’re family,’ and we mean it. There’s no better feeling than creating high-quality jobs right here in the heartland. We’re proud to support American manufacturing and look forward to welcoming more people into our new facility and the Unverferth family.” With the expansion comes a number of upgrades and modernization, including:

Overhead lifts to provide added safety for manufacturing larger parts and components.State-of-the-art LED lighting to provide enhanced visibility while reducing energy requirements.Robotic part-sorting off the laser tables.
Fiber lasers for making high-quality parts with precision.Manufacturing wages start at $23 an hour and second-shift employees receive a $2 per hour shift premium. For more information visit the link

Source : Farm Equipment

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.